Menorrhagia News and Research

RSS

Menorrhagia or heavy periods, is a symptom of an underlying gynaecological condition. Some women may have the condition right from the onset of menses while some develop it during their reproductive period.

Managing menopause: The 2023 toolkit for healthcare practitioners

The authors of the revised 2023 Toolkit extracted key recommendations from professional guidelines and positions as well as consensus statements on menopause and related conditions that have emerged since 2014.

1 Nov 2023

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

Scientists discuss hantavirus infections, which are a type of viral hemorrhagic fever that can be transmitted to humans through exposure to infected rodents in endemic areas.

30 Apr 2023

Can COVID-19 vaccination cause menstrual bleeding changes?

A recent study examined changes in menstrual bleeding following vaccination against SARS-CoV-2 among ethnically and gender-diverse pre-and postmenopausal women.

20 Jul 2022

Many individuals experience menstrual bleeding changes after SARS-CoV-2 vaccination

A new analysis of reports from more than 35,000 people offers the most comprehensive assessment so far of menstrual changes experienced by pre- and post-menopausal individuals in the first two weeks after receiving the COVID-19 vaccine.

15 Jul 2022

COVID-19 vaccines and reports of menstrual disorders

A new study estimates the potential relationship between COVID-19 vaccines and menstrual disorders.

11 Apr 2022

Study finds no strong evidence that COVID-19 vaccination is linked to menstrual changes

A new study reports on the incidence of changes in menstruation in women who have received the COVID-19 vaccine.

18 Nov 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

Providing personalized care for bleeding disorders

An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.

From Takeda 21 Sep 2020

Providing personalized care for bleeding disorders

An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.

From Takeda 21 Sep 2020

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

AEGEA Medical, Inc. has announced the commencement of the Post-Ablation Cavity Access (PACE II) clinical study in women who previously underwent endometrial ablation as part of AEGEA's pivotal trial of the company's patented Adaptive Vapor Ablation technology.

30 Oct 2018

Culture of silence around vaginal bleeding poses threat to women's health

The culture of silence around vaginal bleeding at all stages of life endangers women's health and is compounded by limited access to clean water, sanitation, and factual information in low and middle-income countries, according to a study conducted at Columbia University's Mailman School of Public Health. The findings are published in the online journal BMJ Global Health.

31 Jul 2017

Clinical trial finds women with heavy periods can be greatly helped by GP-prescribed treatments

The largest and longest running clinical trial of medical therapies for heavy periods has found that women can be greatly helped by having treatments just from their GP, with most avoiding hospital operations.

12 Oct 2016

Researchers recommend iron supplementation to women with heavy menstrual bleeding

A study by researchers from Finland found that diagnosis and treatment of anemia is important to improve quality of life among women with heavy periods.

9 Jun 2014

Mirena coil intrauterine device a better treatment for heavy menstrual periods

The hormone-releasing Mirena coil intrauterine device (IUD) is a better treatment for heavy menstrual periods than other conventional medical approaches, according to results of a major clinical trial led by scientists from the Universities of Nottingham and Birmingham.

11 Jan 2013

Hemostatic testing may explain heavy menstrual bleeding

Results of a US study show that hemostatic screening tests are important in the evaluation of young women with heavy menstrual bleeding.

24 Oct 2012

Tranexamic acid: an interview with Prof Ian Roberts

Tranexamic acid is a medicine that reduces blood clot breakdown. In this way it helps in patients with bleeding.

19 Sep 2012

Hysterectomy procedures will continue to decline due to advantages of less-invasive alternatives: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).

27 May 2011

Genesys HTA System receives FDA approval for treatment of menorrhagia

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of its Genesys HTA System for the treatment of menorrhagia. The Genesys HTA System is a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia.

18 May 2010

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

24 Nov 2009

FDA approves Lysteda for treating menorrhagia

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.

16 Nov 2009